Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » RNAssist Licenses Biomolecule Stabilization Tech to QCMD

RNAssist Licenses Biomolecule Stabilization Tech to QCMD

Jan 23, 2020
|
staff reporter

NEW YORK – UK-based technology development company RNAssist said this week that it has licensed its VivoPhix biomolecule stabilization technology to Quality Control for Molecular Diagnostics (QCMD).

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Not Taking the Post

Following discrimination allegations, NICHD's Constantine Stratakis withdraws from a new position at the Research Institute of the McGill University Health Center, Science reports.

Threats Over WHO Funding

US President Donald Trump has threatened to cut World Health Organization funding over its pandemic response, which would affect its ability to do its work and which he might not be able to do.

Sales Stopped

The US Securities and Exchange Commission has halted the sales of a handful of stocks over claims made about the coronavirus.

Nature Papers Examine Single-Cell RNA Sequencing Protocols, Describe New Labeling Approach

In Nature this week: comparative analyses of single-cell RNA sequencing protocols uncover differences between approaches, and more.

What's Popular?

In Business News

  1. Bio-Rad Laboratories Acquires Single-Cell Analysis Firm Celsee

  2. T2 Biosystems Receives Nasdaq Warning Letter

  3. FDA Grants Emergency Use Authorization for BD Coronavirus Test Kit

  4. Qiagen Reports Preliminary Q1 Revenue Growth of 9 Percent

  5. Pacific Biosciences Shares Spike on SARS-CoV-2 Research Initiatives

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.